Positron emission tomography and magnetic resonance imaging in heart failure

Journal of Nuclear Cardiology

Volumn 13, Issue 2, 2006, Pages 145-149

  Bengel, Frank M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA N 13; FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE;

ARTICLE; CELL VIABILITY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; HEALTH CARE COST; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; INTERMETHOD COMPARISON; MEDICAL DECISION MAKING; MORBIDITY; MYOCARDIAL HIBERNATION; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RISK ASSESSMENT; SYSTEMATIC REVIEW; TISSUE PERFUSION;

HEART FAILURE, CONGESTIVE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 33645544147     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02971235     Document Type: Article

References (20)

1. L. Mickleborough H. Maruyama Y. Takagi S. Mohamed Z. Sun L. Ebisuzaki Results of revascularization in patients with severe left ventricular dysfunction Circulation 92 Suppl 1995 II73-II79
2. J.J. Bax W. Wijns J.H. Cornel F.C. Visser E. Boersma P.M. Fioretti Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease comparison of pooled data J Am Coll Cardiol 30 1997 1451-1460
3. M.F. Di Carli M. Davidson R. Little S. Khanna F.V. Mody R.C. Brunken et. al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction Am J Cardiol 73 1994 527-533
4. D. Eitzman Z. al-Aouar H. Kanter J. vom Dahl M. Kirsh G.M. Deeb et. al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography J Am Coll Cardiol 20 1992 559-565
5. R. Beanlands P. Hendry R. Masters R.A. deKemp K. Woodend T.D. Ruddy Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging Circulation 98 Suppl 1998 II51-II56
6. K.G. Tarakji R. Brunken P.M. McCarthy M.O. Al-Chekakie A. Abdel-Latif C.E. Pothier et. al. Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction Circulation 113 2006 230-237
7. F. Haas C.J. Haehnel W. Picker S. Nekolla S. Martinoff H. Meisner et. al. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease J Am Coll Cardiol 30 1997 1693-1700
8. R.S. Beanlands R.A. deKemp S. Smith H. Johansen T.D. Ruddy F-18-fluorodeoxyglucose PET imaging alters clinical decision making in patients with impaired ventricular function Am J Cardiol 79 1997 1092-1095
9. R.J. Gropler E.M. Geltman K. Sampathkumaran J.E. Perez K.B. Schechtman A. Conversano et. al. Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography J Am Coll Cardiol 22 1993 1587-1597
10. F.M. Bengel B. Permanetter M. Ungerer S. Nekolla M. Schwaiger Non-invasive estimation of myocardial efficiency using positron emission tomography and carbon-11 acetate-comparison between the normal and failing human heart Eur J Nucl Med 27 2000 319-326
11. F.M. Bengel M. Schwaiger Assessment of cardiac sympathetic neuronal function using PET imaging J Nucl Cardiol 11 2004 603-616
12. K. Rajappan N.G. Bellenger L. Anderson D.J. Pennell The role of cardiovascular magnetic resonance in heart failure Eur J Heart Fail 2 2000 241-252
13. F.M. Baer E. Voth C.A. Schneider P. Theissen H. Schicha U. Sechtem Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability Circulation 91 1995 1006-1015
14. R.J. Kim E.L. Chen J.A. Lima R.M. Judd Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction Circulation 94 1996 3318-3326
15. A. Wagner H. Mahrholdt T.A. Holly M.D. Elliott M. Regenfus M. Parker et. al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts an imaging study Lancet 361 2003 374-379
16. T.A. Kaandorp H.J. Lamb E.E. van der Wall A. de Roos J.J. Bax Cardiovascular MR to access myocardial viability in chronic ischaemic LV dysfunction Heart 91 2005 1359-1365
17. R.J. Kim E. Wu A. Rafael E.L. Chen M.A. Parker O. Simonetti et. al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction N Engl J Med 343 2000 1445-1453
18. E. Wellnhofer A. Olariu C. Klein M. Grafe A. Wahl E. Fleck et. al. Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery Circulation 109 2004 2172-2174
19. C. Klein S.G. Nekolla F.M. Bengel M. Momose A. Sammer F. Haas et. al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging comparison with positron emission tomography Circulation 105 2002 162-167
20. P.R. Knuesel D. Nanz C. Wyss M. Buechi P.A. Kaufmann G.K. von Schulthess et. al. Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance relation to functional outcome after revascularization Circulation 108 2003 1095-1100